Justin Botillier
Justin Botillier is CEO of Calyx CPA LLC in Southern Oregon. Justin has sixteen years of experience working with small business owners. Prior to recreational legalization he was among the first accounting professionals to advocate for the cannabis industry actively and publicly. In 2016 Justin sold his general practice to work in cannabis full time. He now works with the psychedelic community to prepare business owners for the tax impact of 280E on businesses in the psilocybin industry. His firm specializes in business advisory, entity formation, tax preparation & tax planning for plant medicine companies.
Avoiding the Fall Out of 280E
Due to psychedelics being considered a schedule I drug they are subject to 280E. The tax penalties imposed on these businesses are often their most significant expense and must be taken seriously. Fortunately, there are strategies that can be used to reduce the impact of 280e legally allowing businesses to take aggressive but defensible tax positions.